|
US6156303A
(en)
*
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
EP1690868A1
(en)
|
1997-10-31 |
2006-08-16 |
Maxygen, Inc. |
Modification of virus tropism and host range by viral genome shuffling
|
|
WO2000028004A1
(en)
|
1998-11-10 |
2000-05-18 |
The University Of North Carolina At Chapel Hill |
Virus vectors and methods of making and administering the same
|
|
EP1026250A1
(en)
|
1998-12-02 |
2000-08-09 |
Aventis Behring GmbH |
DNA-constructs of blood clotting factors and P-selectin
|
|
EP1010762A1
(en)
|
1998-12-02 |
2000-06-21 |
Aventis Behring Gesellschaft mit beschränkter Haftung |
DNA constructs of blood clotting factors and P-Selectin
|
|
EP1038959A1
(en)
|
1999-03-17 |
2000-09-27 |
Aventis Behring Gesellschaft mit beschränkter Haftung |
Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX
|
|
EP1048726B1
(en)
|
1999-04-27 |
2006-07-26 |
Négrier, Claude |
Modified factor VIII cDNA
|
|
WO2001068888A2
(en)
|
2000-03-14 |
2001-09-20 |
Neurologix, Inc. |
Production of chimeric capsid vectors
|
|
AU2002248297A1
(en)
|
2001-01-05 |
2002-07-16 |
Children's Hospital, Inc. |
Aav2 vectors and methods
|
|
US7749492B2
(en)
|
2001-01-05 |
2010-07-06 |
Nationwide Children's Hospital, Inc. |
AAV vectors and methods
|
|
US6723551B2
(en)
|
2001-11-09 |
2004-04-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of adeno-associated virus in insect cells
|
|
MX346493B
(es)
|
2001-11-13 |
2017-03-21 |
Univ Pennsylvania |
Un metodo para detectar y/o identificar secuencias del virus adeno-asociado y aislamiento de secuencias novedosas identificadas de ese modo.
|
|
JP4810062B2
(ja)
|
2001-12-17 |
2011-11-09 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
アデノ随伴ウイルス（ａａｖ）血清型８の配列
|
|
AU2003223775A1
(en)
|
2002-04-30 |
2003-11-17 |
Duke University |
Adeno-associated viral vectors and methods for their production from hybrid adenovirus and for their use
|
|
WO2004112727A2
(en)
|
2003-06-19 |
2004-12-29 |
Avigen, Inc. |
Aav virions with decreased immunoreactivity and uses therefor
|
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
CN102199626B
(zh)
|
2003-09-30 |
2015-06-24 |
宾夕法尼亚大学托管会 |
腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
|
|
WO2005072364A2
(en)
|
2004-01-27 |
2005-08-11 |
University Of Florida |
A modified baculovirus expression system for production of pseudotyped raav vector
|
|
EP1828390B1
(en)
|
2004-12-15 |
2012-06-13 |
The University Of North Carolina At Chapel Hill |
Chimeric vectors
|
|
WO2006130639A2
(en)
|
2005-05-31 |
2006-12-07 |
Neurologix, Inc. |
Novel glutamic acid decarboxylase (gad) chimera and methods of use
|
|
US7867484B2
(en)
|
2006-01-27 |
2011-01-11 |
University Of North Carolina At Chapel Hill |
Heparin and heparan sulfate binding chimeric vectors
|
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
|
KR101475088B1
(ko)
|
2006-08-21 |
2014-12-23 |
제넨테크, 인크. |
아자-벤조티오페닐 화합물 및 사용 방법
|
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
|
HRP20161150T1
(hr)
|
2007-04-09 |
2016-11-18 |
University Of Florida Research Foundation, Inc. |
PRIPRAVCI rAAV VEKTORA KOJI IMAJU TIROZIN-MODIFICIRANE CAPSID PROTEINE I POSTUPCI ZA UPORABU
|
|
US20100203083A1
(en)
|
2007-05-31 |
2010-08-12 |
Medigene Ag |
Mutated structural protein of a parvovirus
|
|
US8632764B2
(en)
|
2008-04-30 |
2014-01-21 |
University Of North Carolina At Chapel Hill |
Directed evolution and in vivo panning of virus vectors
|
|
EP2396343B1
(en)
|
2009-02-11 |
2017-05-17 |
The University of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
CN102341406B
(zh)
|
2009-03-04 |
2016-06-08 |
德国癌症研究中心 |
组装活化蛋白（aap）及其用于制备基本上由vp3组成的细小病毒颗粒的应用
|
|
GB0911870D0
(en)
|
2009-07-08 |
2009-08-19 |
Ucl Business Plc |
Optimised coding sequence and promoter
|
|
EP3795581A3
(en)
|
2011-08-24 |
2021-06-09 |
The Board of Trustees of the Leland Stanford Junior University |
New avv capsid proteins for nucleic acid transfer
|
|
ES2609860T3
(es)
|
2011-10-28 |
2017-04-24 |
The University Of North Carolina At Chapel Hill |
Línea celular para la producción de virus adenoasociado
|
|
DK2900686T3
(da)
|
2012-09-28 |
2020-08-17 |
Univ North Carolina Chapel Hill |
Aav-vektorer targeteret til oligodendrocytter
|
|
WO2014064277A1
(en)
|
2012-10-26 |
2014-05-01 |
Vrije Universiteit Brussel |
Vector for liver-directed gene therapy of hemophilia and methods and use thereof
|
|
WO2014159546A1
(en)
|
2013-03-14 |
2014-10-02 |
Asklepios Biopharmaceutical, Inc. |
Modified soluble vegf receptor-1 genes and vectors for gene therapy
|
|
PT2968605T
(pt)
|
2013-03-15 |
2022-09-22 |
Univ North Carolina Chapel Hill |
Métodos e composições para vetores aav de ligação dupla de glicano
|
|
CN105408486B
(zh)
|
2013-05-21 |
2020-07-14 |
佛罗里达大学研究基金会有限公司 |
衣壳修饰的raav3载体组合物以及在人肝癌基因治疗中的用途
|
|
KR102380265B1
(ko)
|
2013-07-22 |
2022-03-29 |
더 칠드런스 호스피탈 오브 필라델피아 |
변종 ａａｖ 및 조성물, 세포, 기관 및 조직으로의 유전자 전이를 위한 방법 및 용도
|
|
ES2936220T3
(es)
|
2013-08-27 |
2023-03-15 |
Res Inst Nationwide Childrens Hospital |
Productos y métodos para el tratamiento de la esclerosis lateral amiotrófica
|
|
PL3459965T3
(pl)
*
|
2013-10-11 |
2021-07-26 |
Massachusetts Eye & Ear Infirmary |
Sposoby przewidywania sekwencji wirusa-przodka i ich zastosowania
|
|
GB201403684D0
(en)
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
|
US20170007720A1
(en)
|
2014-02-21 |
2017-01-12 |
University Of Florida Research Foundation, Inc. |
Methods and compositions for gene delivery to on bipolar cells
|
|
EP3113787B1
(en)
|
2014-03-04 |
2019-12-04 |
University of Florida Research Foundation, Inc. |
Improved raav vectors and methods for transduction of photoreceptors and rpe cells
|
|
ES3050307T3
(en)
|
2014-04-25 |
2025-12-19 |
Genethon |
Nucleic acids comprising a modified intron for use in the treatment of hyperbilirubinemia
|
|
IL248102B
(en)
|
2014-05-02 |
2022-07-01 |
Genzyme Corp |
aav vectors for gene therapy of the central nervous system and retina
|
|
US10577627B2
(en)
|
2014-06-09 |
2020-03-03 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
EP3209311B1
(en)
|
2014-10-21 |
2024-03-06 |
University of Massachusetts |
Recombinant aav variants and uses thereof
|
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
|
KR20170086537A
(ko)
|
2014-11-21 |
2017-07-26 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
중추 신경계에 표적화된 aav 벡터
|
|
GB201502137D0
(en)
|
2015-02-09 |
2015-03-25 |
Ucl Business Plc |
Treatment
|
|
US10648000B2
(en)
|
2015-02-16 |
2020-05-12 |
University Of Florida Research Foundation, Incorporated |
rAAV vector compositions, methods for targeting vascular endothelial cells and use in treatment of type I diabetes
|
|
US20180245073A1
(en)
|
2015-02-23 |
2018-08-30 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
MY187898A
(en)
|
2015-03-02 |
2021-10-27 |
Adverum Biotechnologies Inc |
Compositions and methods for intravitreal delivery of polynucleotides to retinal cones
|
|
EP3277819B1
(en)
|
2015-03-24 |
2021-03-03 |
The Regents of The University of California |
Adeno-associated virus variants and methods of use thereof
|
|
US10081659B2
(en)
|
2015-04-06 |
2018-09-25 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Adeno-associated vectors for enhanced transduction and reduced immunogenicity
|
|
CA3019315A1
(en)
|
2015-04-23 |
2016-10-27 |
University Of Massachusetts |
Modulation of aav vector transgene expression
|
|
GB201508026D0
(en)
*
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Capsid
|
|
SG10202100131WA
(en)
|
2015-06-23 |
2021-02-25 |
Childrens Hospital Philadelphia |
Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues
|
|
US20180216133A1
(en)
|
2015-07-17 |
2018-08-02 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for achieving high levels of transduction in human liver cells
|
|
WO2017023724A1
(en)
|
2015-07-31 |
2017-02-09 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of aadc deficiency
|
|
CN114606267A
(zh)
|
2015-09-28 |
2022-06-10 |
北卡罗来纳-查佩尔山大学 |
逃避抗体的病毒载体的方法和组合物
|
|
WO2017066764A2
(en)
|
2015-10-16 |
2017-04-20 |
William Marsh Rice University |
Modification of n-terminal region of capsid proteins for enhanced properties of adeno-associated viruses
|
|
EP3368054A4
(en)
|
2015-10-28 |
2019-07-03 |
Voyager Therapeutics, Inc. |
REGULATORY EXPRESSION USING THE ADENO-ASSOCIATED VIRUS (AAV)
|
|
MX2018004755A
(es)
|
2015-10-29 |
2018-12-19 |
Voyager Therapeutics Inc |
Entrega de polinucleotidos dirigidos al sistema nervioso central.
|
|
PE20231949A1
(es)
|
2015-10-30 |
2023-12-05 |
Spark Therapeutics Inc |
VARIANTES DEL FACTOR VIII REDUCIDO CON CpG, COMPOSICIONES Y METODOS Y USOS PARA EL TRATAMIENTO DE TRASTORNOS DE LA HEMOSTASIA
|
|
MX2018005084A
(es)
|
2015-11-05 |
2019-05-16 |
Bamboo Therapeutics Inc |
Genes de ataxia de friedreich modificados y vectores para terapia genica.
|
|
US10385320B2
(en)
|
2015-12-02 |
2019-08-20 |
The Board Of Trustees Of The Leland Stanford Junior University |
Recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
|
|
US10406244B2
(en)
|
2015-12-02 |
2019-09-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
AAV vectors with expanded packaging capacity
|
|
ES2869284T3
(es)
|
2015-12-11 |
2021-10-25 |
California Inst Of Techn |
Péptidos de diana para dirigir virus adenoasociados (AAV)
|
|
DK3390429T3
(da)
|
2015-12-14 |
2025-08-25 |
Univ North Carolina Chapel Hill |
Modificerede kapsid-proteiner til forbedret afgivelse af parvovirus-vektorer
|
|
AU2017219865B2
(en)
|
2016-02-16 |
2023-04-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Novel recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
|
|
AU2017234929B2
(en)
|
2016-03-18 |
2024-05-02 |
The Children's Hospital Of Philadelphia |
Therapeutic for treatment of diseases including the central nervous system
|
|
US11433116B2
(en)
|
2016-04-14 |
2022-09-06 |
Cedars-Sinai Medical Center |
GJA1 isoforms protect against metabolic stress
|
|
EP3448875A4
(en)
|
2016-04-29 |
2020-04-08 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
WO2017189959A1
(en)
|
2016-04-29 |
2017-11-02 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
IL302748B1
(en)
|
2016-05-18 |
2025-09-01 |
Voyager Therapeutics Inc |
Modulatory polynucleotides
|
|
CN109843913B
(zh)
|
2016-06-16 |
2024-03-08 |
柏林夏洛特医科大学 |
神经肽表达载体以及用于治疗癫痫的方法
|
|
KR20230161535A
(ko)
|
2016-07-26 |
2023-11-27 |
바이오마린 파머수티컬 인크. |
신규 아데노-관련 바이러스 캡시드 단백질
|
|
EP3497207B1
(en)
|
2016-08-15 |
2021-01-06 |
Genzyme Corporation |
Methods for detecting aav
|
|
MX2019002518A
(es)
|
2016-09-02 |
2019-07-18 |
Spark Therapeutics Inc |
Metodos y vectores para el tratamiento de trastornos del snc.
|
|
EP3293203A1
(en)
|
2016-09-12 |
2018-03-14 |
Genethon |
Acid-alpha glucosidase variants and uses thereof
|
|
AU2017322376B2
(en)
|
2016-09-12 |
2023-08-17 |
Association Institut De Myologie |
Acid-alpha glucosidase variants and uses thereof
|
|
EP3293259A1
(en)
|
2016-09-12 |
2018-03-14 |
Genethon |
Acid-alpha glucosidase variants and uses thereof
|
|
EP3526333A4
(en)
|
2016-10-13 |
2020-07-29 |
University of Massachusetts |
AAV CAPSIDE DESIGNS
|
|
CN110545827A
(zh)
|
2016-10-27 |
2019-12-06 |
因提玛生物科学公司 |
T细胞治疗的病毒方法
|
|
BR112019016769A2
(pt)
|
2017-02-15 |
2020-05-26 |
The University Of North Carolina At Chapel Hill |
Métodos e composições para transferência genética através da vasculatura
|
|
CA3053455A1
(en)
|
2017-03-10 |
2018-09-13 |
Genethon |
Treatment of glycogen storage disease iii
|
|
WO2018170310A1
(en)
|
2017-03-15 |
2018-09-20 |
The University Of North Carolina At Chapel Hill |
Polyploid adeno-associated virus vectors and methods of making and using the same
|
|
US20200370039A1
(en)
|
2017-04-11 |
2020-11-26 |
Ruprecht-Karls-Universitat Heidelberg |
Adeno-associated virus library
|
|
WO2018200419A1
(en)
|
2017-04-23 |
2018-11-01 |
The Trustees Of The University Of Pennsylvania |
Viral vectors comprising engineered aav capsids and compositions containing the same
|
|
US11752181B2
(en)
|
2017-05-05 |
2023-09-12 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating Huntington's disease
|
|
EP3618839A4
(en)
|
2017-05-05 |
2021-06-09 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
PE20251181A1
(es)
|
2017-06-07 |
2025-04-23 |
Spark Therapeutics Inc |
Agentes potenciadores para la transfeccion celular mejorada y/o la produccion del vector raav
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
JP2020526190A
(ja)
|
2017-06-30 |
2020-08-31 |
スパーク セラピューティクス インコーポレイテッドＳｐａｒｋ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
Ａａｖベクターのカラム精製方法
|
|
CN111630170B
(zh)
|
2017-07-31 |
2025-03-07 |
映像生物有限公司 |
眼部疾病的细胞模型及用于眼部疾病的疗法
|
|
AU2018312565A1
(en)
|
2017-08-01 |
2020-02-27 |
Spark Therapeutics, Inc. |
Factor VIII (FVIII) gene therapy methods
|
|
CN111448308A
(zh)
|
2017-08-03 |
2020-07-24 |
沃雅戈治疗公司 |
递送aav的组合物和方法
|
|
WO2019043081A1
(en)
|
2017-08-29 |
2019-03-07 |
Ruprecht-Karls-Universität Heidelberg |
RATIONALLY DESIGNED PSEUDOVIRAL PARTICLES FOR THE MODULATION OF CHIMERIC ANTIGENIC RECEPTOR (CAR) T CELL THERAPY
|
|
WO2019060649A1
(en)
|
2017-09-22 |
2019-03-28 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE
|
|
WO2019073059A1
(en)
|
2017-10-12 |
2019-04-18 |
Freeline Therapeutics Limited |
ADENOVIRAL AUXILIARY VIRUSES WITH DEFECTIVE CYCLE LIFE, PRODUCTION AND USE FOR THE PRODUCTION OF RAAV
|